YahooSeptember 5, 2026 at 12:18 AM NY4 hours ago
What Does Moderna (MRNA) Bird Flu Phase 3 Trial Mean For Its Growth?
Moderna (NasdaqGS:MRNA) has started a Phase 3 trial of its mRNA based bird flu vaccine, moving the program into late stage testing. The trial is supported by a major international partnership focused on pandemic preparedness. Moderna has tied the program to commitments for equitable global access, including reserved manufacturing capacity for low and middle income countries. This push into mRNA vaccines for emerging infectious diseases points to a wider theme in healthcare that is worth...
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo
Companies in This Story
Related Stories
Is Moderna (MRNA) Fully Valued After Its New 2032 Convertible Notes?
Yahoo8 hours ago
Why Atlassian Stock Skyrocketed 92% Higher in August and Why There's Likely More to Come
Yahoo1 hour ago
CEO Brian Niccol Just Announced Incredible News for Starbucks Investors
Yahoo1 hour ago
Here's How Many Shares of Coca-Cola You'd Need for $40,000 in Yearly Dividends
Yahoo1 hour ago
Berkshire Hathaway Outperformed the S&P 500 Over a 60-Year Period Under Warren Buffett. Here's the Stock That Could Help Continue the Streak Under Greg Abel.
Yahoo3 hours ago